Login / Signup

Safety of autologous stem cell transplantation in patients with known Human T-cell Lymphotropic Viruses Type 1 and 2 infection: A case series of four patients.

Vishal K GuptaPaul S WhiteDina BrauneisAnthony C SheltonKaren QuillenVaishali SanchorawalaShayna R SarosiekJohn Mark Sloan
Published in: American journal of hematology (2019)
Keyphrases
  • stem cell transplantation
  • end stage renal disease
  • high dose
  • endothelial cells
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • bone marrow
  • low dose